Urinary IncontinenceEVRPNCT07105150
Efficacy of a Video-Based Educational Program on Female Urinary Incontinence
A study testing video-based education program and written information in people with Urinary Incontinence, run by Poitiers University Hospital at 12 sites in France.
Trial summary
The aim of this clinical trial is to assess the effectiveness of a 4-week video-based education program in enhancing urinary continence among women with urinary incontinence referred for pelvic floor rehabilitation The main question it aims to answer is : Does a structured video-based education program reduce the… Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Urinary Incontinence
- What is being tested?
- video-based education program and written information
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 144 participants
- Where
- 12 sitesFrance
- Study dates
- 9 Jan 2026to 9 Jan 2030
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Any woman referred for pelvic floor rehabilitation sessions for urinary incontinence (defined as 'any involuntary leakage reported by the patient' according to the International Continence Society)
- Women requiring perineal rehabilitation for urinary incontinence
- Aged 18 years or older
- Having access to a connected device (tablet, smartphone, computer)
- Having a functional email address
- Covered by a social security scheme
- Informed, and written consent (signed by the participant and the investigator)
Who cannot join
- Women unable to complete questionnaires (unable to read French or unable to write)
- Visually impaired individuals who cannot watch the video or read the printed material
- Genital prolapse extending beyond the hymen
- Documented neurological disorders
- Individuals receiving psychiatric care and those unable to express their consent
- History of pelvic fractures or dorsolumbar surgery
Show all 9Show fewer
- Chronic pelvic pain
- Women who have given birth within the last 6 month
- Individuals with enhanced protection: minors, individuals deprived of liberty, individuals residing in a health or social institution, pregnant or breastfeeding women, adults under legal protection, and patients in emergency situations.
Trial locations and contacts
12 sites in 1 country. Contact the study team or a site near you to ask about taking part.
12 sites in 1 country
France12 sites, 12 recruiting
- Not yet recruiting
Mme ROSSIGNOL Marie - Kinésithérapeute - 5 place du Lavoir
Buxy, 71390
Marie ROSSIGNOL, 06 47 85 08 52, marie.longissor@gmail.com
- Recruiting
Mme BLANCHARD Véronique - Kinésithérapeute
Chanceaux-sur-Choisille, 37390
Blanchard Véronique, +33 6 14 22 28 85, veronique.blanchard@etude-evrp.fr
- Not yet recruiting
Mme GIRARD Delphine - kinésithérapeute - 14 rue de la Liberté
Embrun, 05200
Delphine GIRARD, 06 75 91 07 44, kine.dgirard@gmail.com
- Recruiting
Mme LIAGRE Blandine - Kinésithérapeute - 120 rue de Chanzy
Hellemmes-Lille, 59260
Blandine LIAGRE, 0684874530, blweerts@gmail.com
- Not yet recruiting
Mme BESSON Alice - Kinésithérapeute - 22 rue Benjamin Franklin
La Roche-sur-Yon, 85000
Alice BESSON, 02 51 46 98 57, besson.mk@gmail.com
- Not yet recruiting
Mme OLIVIER Mathilde - Groupe médical du Barry - 34 Bis Rue du Quatre Septembre
Montignac, 24290
Mathilde OLIVIER, 06 19 14 00 25, mathildeolivier21@gmail.com
- Not yet recruiting
Mme CALONNE Hélène - Kinésithérapeute - 23 rue Franiatte
Montigny-lès-Metz, 57950
Hélène CALONNE, 06 32 33 93 61, ln.calonne@gmail.com
- Not yet recruiting
Mme LE TILLY Marine - Kinésithérapeute - 181 rue Legendre
Paris, 75017
Marine LE TILLY, 06 72 50 18 26, marine.letilly@hotmail.fr
- Not yet recruiting
Mme GIEN Isabelle - Kinésithérapeute - 2 Rue Adrienne Bolland
Saint-Jean-de-Braye, 45800
Isabelle GIEN, 02 38 61 43 00, isachauvat@gmail.com
- Recruiting
Mme LACOMBE Florence - Kinésithérapeute - 2 Rue Gabriel Durand
Saint-Médard-en-Jalles, 33160
Florence LACOMBE, 05 56 47 42 49, flodel.kine@gmail.com
- Recruiting
Mme RIERE Claire - Kinésithérapeute - 62 Route de Saint-Aubin
Saint-Médard-en-Jalles, 53218
Claire RIERE, 06 03 85 74 12, cadulapepette@hotmail.fr
- Recruiting
Mme GRUYER DROUET Laurence - Kinésithérapeute - 7 Rue Jean Baptiste Clément
Villejuif, 94800
Laurence GRUYER DROUET, 01 86 22 01 23, laurencegruyerdrouet@club-internet.fr
About this study
Official title: Efficacy of an Educational Video-Based Program to Treat Urinary Incontinence in Women Referred for Pelvic Floor Rehabilitation
The aim of this clinical trial is to assess the effectiveness of a 4-week video-based education program in enhancing urinary continence among women with urinary incontinence referred for pelvic floor rehabilitation
The main question it aims to answer is :
Read more
- Does a structured video-based education program reduce the symptoms of urinary incontinence before any pelvic floor muscle strengthening ? Researchers will compare this program to a paper document (providing similar information) to see if this improves urinary continence in women suffering from urinary incontinence.
Participants will :
- receive either the video-based education program or a paper information document (providing similar information) prior to the sessions with the physiotherapist
- then follow pelvic floor rehabilitation sessions with the physiotherapist according to usual practice
- complete the urinary incontinence questionnaire after the 4-week video education program (intervention group) or 4 weeks after receiving the paper document (control group), and after each pelvic floor rehabilitation session with the physiotherapist and at the end of the sessions
- will be monitored at 1 and 2 years to evaluate urinary incontinence following the intervention.
Read the detailed description
The video-based education program will include 4 workshops of 20 minutes each, at a rate of 1 video per week:
Video 1: Anatomy and physiology of the pelvic floor; Video 2: Physiology of the urinary tract; Video 3: Physiology of the digestive tract; Video 4: Pathophysiology of urinary incontinence and other pelvic floor disorders (genital prolapse and anal incontinence) and preventive measures in daily activities.
- Conditions
- Urinary Incontinence
- Being tested
- video-based education program, written information
- Keywords
- urinary incontinence, pelvic floor rehabilitation, video-based program, education
- Medical subject headings
- Urinary Incontinence
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
video-based education programBehavioural
The video-based education program will include 4 workshops of 20 minutes each, at a rate of 1 video per week:
Video 1: Anatomy and physiology of the pelvic floor; Video 2: Physiology of the urinary tract; Video 3: Physiology of the digestive tract; Video 4: Pathophysiology of urinary incontinence and other pelvic floor disorders (genital prolapse and anal incontinence) and preventive measures in daily activities.
written informationOther
The control group will receive a paper information document (containing the same information as the intervention group) during the 4-week period
| Study group | Role | What they receive |
|---|---|---|
| video-based education program group | Experimental | Not described Receives: Behavioral: video-based education program |
| written information group | Active comparator | Not described Receives: Other: written information |
What is being measured
The primary outcome is the main question the study is designed to answer.
Urinary incontinence score comparison between the 2 groups
the urinary incontinence score will measured using the ICIQ-SF (International Consultation on Incontinence Questionnaire-Short Form), ranging from 0 (corresponding to 'no urinary incontinence') to 21 (corresponding to 'very severe urinary incontinence'), collected after the video-based education program in the intervention group (scheduled over 4 weeks) and within the same timeframe in the control group (which received only the information document)
Measured: At the end of the video-based education program (5 weeks after inclusion)
Secondary outcomes (25)
Urinary incontinence score evolution in the intervention group
Change in urinary incontinence score (International Consultation on Incontinence Questionnaire- Short Form, ICIQ-SF, ranging from 0 = 'no incontinence' to 21 = 'very severe incontinence') between inclusion and the end of the video education program in the intervention group (scheduled over 4 weeks)
Measured: from inclusion until the end of the video education program (5 weeks after inclusion)
Urinary incontinence score evolution in the control group
Change in urinary incontinence score (International Consultation on Incontinence Questionnaire- Short Form, ICIQ-SF, ranging from 0 = 'no incontinence' to 21 = 'very severe incontinence') between inclusion and 5 weeks following the distribution of the paper information document
Measured: from inclusion to 5 weeks following the distribution of the paper information document
Number of pelvic floor rehabilitation sessions required in the intervention group
The number of rehabilitation sessions needed to achieve a reduction of 3 points or more in the urinary incontinence score (ICIQ-SF) - a difference considered clinically significant - or a reduction of less than 3 points, provided that the decrease is deemed sufficient or satisfactory by the physiotherapist
Measured: ICIQ-SF score recorded after each pelvic floor rehabilitation session, through end of rehabilitation, an average of 3 months
Number of pelvic floor rehabilitation sessions required in the control group
The number of rehabilitation sessions needed to achieve a reduction of 3 points or more in the urinary incontinence score (ICIQ-SF) - a difference considered clinically significant - or a reduction of less than 3 points, provided that the decrease is deemed sufficient or satisfactory by the physiotherapist
Measured: ICIQ-SF score recorded after each pelvic floor rehabilitation session, through end of rehabilitation, an average of 3 months
Urinary incontinence score evolution during the pelvic floor rehabilitation sessions in the intervention group
The variation in the urinary incontinence score (ICIQ-SF) from first pelvic floor rehabilitation session to the 10th session and up to the last session
Measured: ICIQ-SF score recorded after each pelvic floor rehabilitation session, through end of rehabilitation, an average of 3 months
Urinary incontinence score evolution during the pelvic floor rehabilitation sessions in the control group
The variation in the urinary incontinence score (ICIQ-SF) from first pelvic floor rehabilitation session to the 10th session and up to the last session
Measured: ICIQ-SF score recorded after each pelvic floor rehabilitation sessions, through end of rehabilitation, an average of 3 months
Quality of life score evolution in the intervention group
The difference in the quality of life score associated with urinary symptoms (specific CONTILIFE questionnaire) and general quality of life (EuroQoL-5D questionnaire) at inclusion and after the video-based education program , as well as between inclusion and at the end of the pelvic floor rehabilitation sessions
Measured: at inclusion and after the video-based education program (5 weeks after inclusion) , as well as between inclusion and at the end of the pelvic floor rehabilitation sessions, an average of 3 months
Quality of life score evolution in the control group
The difference in the quality of life score associated with urinary symptoms (specific CONTILIFE questionnaire) and general quality of life (EuroQoL-5D questionnaire) at inclusion and 5 weeks after the distribution of the paper document information, as well as between inclusion and at the end of the pelvic floor rehabilitation sessions
Measured: at inclusion and 5 weeks after the distribution of the paper document information, as well as between inclusion and at the end of the pelvic floor rehabilitation sessions, an average of 3 months
Pelvic floor and sexual symptoms scores evolution in the intervention group
The difference in the score for pelvic floor and sexual symptoms that may be associated with urinary incontinence (FPFQ - Female Pelvic Floor Questionnaire) between inclusion and the end of the video-based education program, as well as between inclusion and the end of the pelvic floor rehabilitation sessions
Measured: between inclusion and the end of the video-based education program (5 weeks after inclusion), as well as between inclusion and the end of the pelvic floor rehabilitation sessions, an average of 3 months
Pelvic floor and sexual symptoms scores evolution in the control group
The difference in the score for pelvic floor and sexual symptoms that may be associated with urinary incontinence (FPFQ - Female Pelvic Floor Questionnaire) between inclusion and 4 weeks after the distribution of the paper information document, as well as between inclusion and the end of the pelvic floor rehabilitation sessions
Measured: at inclusion and 5 weeks after the distribution of the paper information document, as well as between inclusion and the end of the pelvic floor rehabilitation sessions, an average of 3 months
Patient-perceived improvement score evolution in the intervention group
Patient-perceived improvement score evaluated by the PGII (Patient Global Impression of Improvement) questionnaire after the video-based education program and at the end of the pelvic floor rehabilitation sessions
Measured: after the video-based education program (5 weeks after inclusion)and at the end of the pelvic floor rehabilitation sessions, an average of 3 months
Patient-perceived improvement score evolution in the control group
Patient-perceived improvement score evaluated by the PGII (Patient Global Impression of Improvement) questionnaire 5 weeks after the distribution of the paper information document and at the end of the pelvic floor rehabilitation sessions
Measured: 5 weeks after inclusion and at the end of the pelvic floor rehabilitation sessions, an average of 3 months
Patient-perceived improvement score evolution according to the urinary incontinence type in the intervention group
Patient-perceived improvement score evaluated by the PGII (Patient Global Impression of Improvement) questionnaire after the video-based education program and at the end of the pelvic floor rehabilitation sessions, according to the urinary incontinence type (Stress urinary incontinence, Urge urinary incontinence and mixed incontinence)
Measured: after the video-based education program (5 weeks after inclusion) and at the end of the pelvic floor rehabilitation sessions, an average of 3 months)
Patient-perceived improvement score evolution according to the type of urinary incontinence
Patient-perceived improvement score evaluated by the PGII (Patient Global Impression of Improvement) questionnaire 5 weeks after the distribution of the paper information document and at the end of the pelvic floor rehabilitation sessions, according to the urinary incontinence type (Stress urinary incontinence, Urge urinary incontinence and mixed incontinence)
Measured: 5 weeks after inclusion and at the end of the pelvic floor rehabilitation sessions, an average of 3 months
Patient-perceived improvement score evolution according to the dimensions of the Urinary Leakage Circumstances questionnaire in the intervention group
Patient-perceived improvement score evaluated by the PGII (Patient Global Impression of Improvement) questionnaire after the video-based education program and at the end of the pelvic floor rehabilitation sessions, according to the dimensions of the Urinary Leakage Circumstances questionnaire (ULCQ)
Measured: after the video-based education program (5 weeks after inclusion) and at the end of the pelvic floor rehabilitation sessions, an average of 3 months
Patient-perceived improvement score evolution according to the dimensions of the Urinary Leakage Circumstances questionnaire in the control group
Patient-perceived improvement score evaluated by the PGII (Patient Global Impression of Improvement) questionnaire 5 weeks after the disctribution of the paper information document and at the end of the pelvic floor rehabilitation sessions, according to the dimensions of the Urinary Leakage Circumstances questionnaire (ULCQ)
Measured: 5 weeks after inclusion and at the end of the pelvic floor rehabilitation sessions, an average of 3 months
ICIQ-SF score evolution 12 and 24 month after the end of the pelvic floor rehabilitation sessions in the intervention group
Difference between the ICIQ-SF score at the end of the pelvic floor rehablitation sessions and the ICIQ-SF score at 12 months and at 24 months in the intervention group
Measured: at the end of the pelvic floor rehablitation sessions and after 12 and 24 months
ICIQ-SF score evolution at 12 and 24 months after the end of the pelvic floor rehabilitation sessions
Difference between the ICIQ-SF score at the end of the pelvic floor rehablitation sessions and the ICIQ-SF score at 12 months and at 24 months in the control group
Measured: at the end of the pelvic floor rehablitation sessions and after 12 and 24 months
Urinary incontinence management 12 and 24 months after the end of the pelvic floor rehabilitation sessions in the intervention group
New management of urinary incontinence, defined by new pelvic floor rehabilitation sessions, urinary incontinence or prolapse surgery, initiation of anticholinergic treatment, or any other therapy for urinary urinary at 12 and 24 months
Measured: at 12 and 24 months
Urinary incontinence management 12 and 24 months after the end of the pelvic floor rehabilitation sessions in the control group
New management of urinary incontinence, defined by new pelvic floor rehabilitation sessions, urinary incontinence or prolapse surgery, initiation of anticholinergic treatment, or any other therapy for urinary urinary at 12 and 24 months
Measured: at 12 and 24 months
Impact of the videos on Knowledge and Satisfaction Ratings
Difference in correct answers on questionnaires before and after each video, and satisfaction rating (0 to 10) after each video of the program
Measured: after each video of the program, once a week for 4 weeks
Usage of the videos provided in the intervention group
number of views for each video, time of day, total time spent on viewings (automatically collected via the connection platform)
Measured: at the end of the video-based education program, 5 weeks after inclusion
Physical activity evolution after pelvic floor rehabilitation in the entire population and afetr 12 and 24 months
Compare the evolution of physical activity practice (intensity) from inclusion to the end of the pelvic floor rehabilitation sessions and after 12 and 24 months
Measured: from inclusion to the end of the pelvic floor rehabilitation sessions (an average of 3 months), and after 12 and 24 months after the end of rehabilitation
Urinary incontinence score between the 2 groups according the UI type
ICIQ-SF score at the end of the video-based education program vs the paper information document according to the UI type
Measured: at the end of the video-based education program versus the paper information document, 5 weeks after inclusion
Urinary incontinence score according to the dimensions of the Urinary Leakage Questionnaire
to compare the ICIQ-SF score in each of the dimensions of the urinary leakage circumstances questionnaire after the video-based education program versus the paper information document
Measured: after the video-based education program, 5 weeks after inclusion
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Aug 2025
- Study start9 Jan 2026
- Primary completion15 Feb 2028 (estimated)
- Study completion9 Jan 2030 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Urinary IncontinenceStudies of the same condition, open and under way.
- More trials run by Poitiers University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 144 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Poitiers University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Anne Cecile Pizzoferrato, M.D, Study director, University Hospital Center of Poitiers
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07105150
- Sponsor's protocol ID
- 2025-A00419-40
- Acronym
- EVRP
- Status last verified
- Jan 2026
- First submitted
- 12 Jul 2025
- Last updated
- 10 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 10 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Efficacy of an Educational Video-Based Program to Treat Urinary Incontinence in Women Referred for Pelvic Floor Rehabilitation
- ClinicalTrials.gov ID
- NCT07105150
- Acronym / sponsor ID
- EVRP / 2025-A00419-40
- Conditions
- Urinary Incontinence
- Keywords
- urinary incontinence, pelvic floor rehabilitation, video-based program, education
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 144 participants (estimated)
- Lead sponsor
- Poitiers University HospitalUniversity, hospital or other
- Study start
- 9 Jan 2026 (actual)
- Primary completion
- 15 Feb 2028 (estimated)
- Study completion
- 9 Jan 2030 (estimated)
- First posted
- 5 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this clinical trial is to assess the effectiveness of a 4-week video-based education program in enhancing urinary continence among women with urinary incontinence referred for pelvic floor rehabilitation
The main question it aims to answer is :
- Does a structured video-based education program reduce the symptoms of urinary incontinence before any pelvic floor muscle strengthening ? Researchers will compare this program to a paper document (providing similar information) to see if this improves urinary continence in women suffering from urinary incontinence.
Participants will :
- receive either the video-based education program or a paper information document (providing similar information) prior to the sessions with the physiotherapist
- then follow pelvic floor rehabilitation sessions with the physiotherapist according to usual practice
- complete the urinary incontinence questionnaire after the 4-week video education program (intervention group) or 4 weeks after receiving the paper document (control group), and after each pelvic floor rehabilitation session with the physiotherapist and at the end of the sessions
- will be monitored at 1 and 2 years to evaluate urinary incontinence following the intervention.
Detailed description
The video-based education program will include 4 workshops of 20 minutes each, at a rate of 1 video per week:
Video 1: Anatomy and physiology of the pelvic floor; Video 2: Physiology of the urinary tract; Video 3: Physiology of the digestive tract; Video 4: Pathophysiology of urinary incontinence and other pelvic floor disorders (genital prolapse and anal incontinence) and preventive measures in daily activities.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| video-based education program group | Experimental | Behavioral: video-based education program |
| written information group | Active comparator | Other: written information |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Any woman referred for pelvic floor rehabilitation sessions for urinary incontinence (defined as 'any involuntary leakage reported by the patient' according to the International Continence Society)
- Women requiring perineal rehabilitation for urinary incontinence
- Aged 18 years or older
- Having access to a connected device (tablet, smartphone, computer)
- Having a functional email address
Key exclusion criteria (9 listed)
- Women unable to complete questionnaires (unable to read French or unable to write)
- Visually impaired individuals who cannot watch the video or read the printed material
- Genital prolapse extending beyond the hymen
- Documented neurological disorders
- Individuals receiving psychiatric care and those unable to express their consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| video-based education programThe video-based education program will include 4 workshops of 20 minutes each, at a rate of 1 video per week: Video 1: Anatomy and physiology of the pelvic floor; Video 2: Physiology of the urinary tract; Video 3: Physiology of the digestive tract; Video 4: Pathophysiology of urinary incontinence and other pelvic floor disorders (genital prolapse and anal incontinence) and preventive measures in daily activities. | Behavioural | video-based education program group |
| written informationThe control group will receive a paper information document (containing the same information as the intervention group) during the 4-week period | Other | written information group |
Primary outcome
Urinary incontinence score comparison between the 2 groups
Time frame: At the end of the video-based education program (5 weeks after inclusion)
the urinary incontinence score will measured using the ICIQ-SF (International Consultation on Incontinence Questionnaire-Short Form), ranging from 0 (corresponding to 'no urinary incontinence') to 21 (corresponding to 'very severe urinary incontinence'), collected after the video-based education program in the intervention group (scheduled over 4 weeks) and within the same timeframe in the control group (which received only the information document)
25 secondary outcomes
Urinary incontinence score evolution in the intervention group
Time frame: from inclusion until the end of the video education program (5 weeks after inclusion)
Urinary incontinence score evolution in the control group
Time frame: from inclusion to 5 weeks following the distribution of the paper information document
Number of pelvic floor rehabilitation sessions required in the intervention group
Time frame: ICIQ-SF score recorded after each pelvic floor rehabilitation session, through end of rehabilitation, an average of 3 months
Number of pelvic floor rehabilitation sessions required in the control group
Time frame: ICIQ-SF score recorded after each pelvic floor rehabilitation session, through end of rehabilitation, an average of 3 months
Urinary incontinence score evolution during the pelvic floor rehabilitation sessions in the intervention group
Time frame: ICIQ-SF score recorded after each pelvic floor rehabilitation session, through end of rehabilitation, an average of 3 months
Urinary incontinence score evolution during the pelvic floor rehabilitation sessions in the control group
Time frame: ICIQ-SF score recorded after each pelvic floor rehabilitation sessions, through end of rehabilitation, an average of 3 months
Quality of life score evolution in the intervention group
Time frame: at inclusion and after the video-based education program (5 weeks after inclusion) , as well as between inclusion and at the end of the pelvic floor rehabilitation sessions, an average of 3 months
Quality of life score evolution in the control group
Time frame: at inclusion and 5 weeks after the distribution of the paper document information, as well as between inclusion and at the end of the pelvic floor rehabilitation sessions, an average of 3 months
Pelvic floor and sexual symptoms scores evolution in the intervention group
Time frame: between inclusion and the end of the video-based education program (5 weeks after inclusion), as well as between inclusion and the end of the pelvic floor rehabilitation sessions, an average of 3 months
Pelvic floor and sexual symptoms scores evolution in the control group
Time frame: at inclusion and 5 weeks after the distribution of the paper information document, as well as between inclusion and the end of the pelvic floor rehabilitation sessions, an average of 3 months
Patient-perceived improvement score evolution in the intervention group
Time frame: after the video-based education program (5 weeks after inclusion)and at the end of the pelvic floor rehabilitation sessions, an average of 3 months
Patient-perceived improvement score evolution in the control group
Time frame: 5 weeks after inclusion and at the end of the pelvic floor rehabilitation sessions, an average of 3 months
Patient-perceived improvement score evolution according to the urinary incontinence type in the intervention group
Time frame: after the video-based education program (5 weeks after inclusion) and at the end of the pelvic floor rehabilitation sessions, an average of 3 months)
Patient-perceived improvement score evolution according to the type of urinary incontinence
Time frame: 5 weeks after inclusion and at the end of the pelvic floor rehabilitation sessions, an average of 3 months
Patient-perceived improvement score evolution according to the dimensions of the Urinary Leakage Circumstances questionnaire in the intervention group
Time frame: after the video-based education program (5 weeks after inclusion) and at the end of the pelvic floor rehabilitation sessions, an average of 3 months
Patient-perceived improvement score evolution according to the dimensions of the Urinary Leakage Circumstances questionnaire in the control group
Time frame: 5 weeks after inclusion and at the end of the pelvic floor rehabilitation sessions, an average of 3 months
ICIQ-SF score evolution 12 and 24 month after the end of the pelvic floor rehabilitation sessions in the intervention group
Time frame: at the end of the pelvic floor rehablitation sessions and after 12 and 24 months
ICIQ-SF score evolution at 12 and 24 months after the end of the pelvic floor rehabilitation sessions
Time frame: at the end of the pelvic floor rehablitation sessions and after 12 and 24 months
Urinary incontinence management 12 and 24 months after the end of the pelvic floor rehabilitation sessions in the intervention group
Time frame: at 12 and 24 months
Urinary incontinence management 12 and 24 months after the end of the pelvic floor rehabilitation sessions in the control group
Time frame: at 12 and 24 months
Impact of the videos on Knowledge and Satisfaction Ratings
Time frame: after each video of the program, once a week for 4 weeks
Usage of the videos provided in the intervention group
Time frame: at the end of the video-based education program, 5 weeks after inclusion
Physical activity evolution after pelvic floor rehabilitation in the entire population and afetr 12 and 24 months
Time frame: from inclusion to the end of the pelvic floor rehabilitation sessions (an average of 3 months), and after 12 and 24 months after the end of rehabilitation
Urinary incontinence score between the 2 groups according the UI type
Time frame: at the end of the video-based education program versus the paper information document, 5 weeks after inclusion
Urinary incontinence score according to the dimensions of the Urinary Leakage Questionnaire
Time frame: after the video-based education program, 5 weeks after inclusion
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Feb 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Urinary Incontinence
Not yet recruiting
Radiofrequency and Pelvic Floor-Core Exercise for Chronic Low Back Pain in Women With Pelvic Floor Dysfunction
Chronic Low Back Pain, Urinary Incontinence
RecruitingObservational study
Standardized 4D Transperineal Ultrasound Assessment of Urethrovesical Junction Mobility After Vaginal Laser Treatment for Stress Urinary Incontinence.
Urinary Incontinence , Stress, Laser Therapy
Not yet recruiting
Feasibility of Resisted Expiratory Muscle Training for Females Assigned at Birth With Stress Urinary Incontinence: A Pilot Study
Stress Urinary Incontinence
RecruitingPhase 2
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
Urinary Urge Incontinence, Stress Urinary Incontinence
RecruitingPhase 4
Prophylactic Antibiotics for Outpatient Urethral Bulking
Urinary Tract Infections, Stress Urinary Incontinence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Anne Cecile Pizzoferrato, M.D study director
University Hospital Center of Poitiers
12 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing video-based education program and written information in people with Urinary Incontinence, run by Poitiers University Hospital at 12 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 10 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 12 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Veronique Blanchard (+33614222885, verobmsb@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Urinary incontinence score comparison between the 2 groups (time frame: At the end of the video-based education program (5 weeks after inclusion)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Feb 2026.